mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.1 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |